APP and Alzheimer disease: Since lipid biochemistry is disrupted in AD (10, 26) and given that one of the main neuropathological characteristics involved in AD pathogenesis implicates the APP (27, 28), which we have previously reported decreases both cholesterol and FA biosynthesis when its expression level increases (23), we wondered whether modifications in PPARA expression observed could be related to hAPP expression.